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The electrical admittance of myocardium can be used to distinguish between 
stunned, ischemic and necrotic myocardial tissue. Myocardial stunning is the reversible 
contractile dysfunction following a brief ischemic episode. This reversible nature is 
clinically significant and is in contrast to the irreversible myocardial dysfunction that 
occurs with necrosis. This dissertation aims at developing an instrument to measure 
myocardial admittance during ischemia and subsequent reperfusion and to study the 
underlying mechanisms governing the onset and progression of ischemia and stunning. 
The instrument was tested on Langendorff models of the isolated rat heart that has been 
subjected to varying durations of global no flow ischemia and subsequent reperfusion. 
The relative permittivity and conductivity of the myocardium was determined and this 
could be correlated to the state of the tissue.  
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Ischemic heart disease is the single leading cause of death in the United States and 
in the developed world. Overall, there are an estimated 71.3 million people in the United 
States living with cardiovascular diseases (CVD), which causes over 910,000 deaths 
annually compared to over 554,000 cancer deaths. In 2003, it was reported that 13.2 
million Americans suffered from coronary heart disease (CHD) [58] and CHD was the 
cause of 1 in every 5 deaths in the country. The estimated direct and indirect cost of CHD 
was US$142 billion in 2006. 
Ischemia is a restriction in blood supply caused by constriction or blockage of the 
blood vessels, resulting in tissue damage or dysfunction. Insufficient blood supply causes 
the tissue to become hypoxic or anoxic (if no oxygen is supplied at all). This can cause 
tissue necrosis, usually within 10-12 hours. Ischemia of the heart muscle results in a 
condition called angina pectoris which could result in a myocardial infarction. This can 
be due to atherosclerosis, thromboembolism, tachycardia, hypotension, or other causes.  
Ischemia may also be inadvertently induced during certain surgical procedures or 
during the storage and transport of donor hearts prior to transplantation. This has an 
adverse effect on the cardiac cells, which determines the further viability of the heart. 
Hence any parameter that can monitor the onset and progression of myocardial ischemia, 
such as electrical admittance, could find widespread use in medicine as a real time 
ischemia detector. 
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Myocardial ischemia is known to change electrical properties of the myocardium 
[6, 41, 47, 48]. Both the conductive and capacitive behavior of myocardium change in 
response to an ischemic event. This may enable the real time monitoring of the onset and 
progression of ischemia by measuring the electrical conductivity and permittivity of the 
cardiac muscle. 
Patients undergoing vascular surgery have a high risk of suffering major post 
operative cardiac events. There is an increased correlation of adverse cardiac events with 
the presence of perioperative myocardial ischemia [25, 44]. High risk patients display an 
increased frequency of tachycardia and asymptomatic ischemia in the first 48 hrs post 
operatively, with ischemia almost uniformly preceding adverse cardiac events [35, 43, 
44]. All this has indicated the need for reliable ischemia monitoring. Urban et al. [59] 
have shown that clinically available hemodynamic indicators cannot identify 
intraoperative myocardial ischemia. 
All measures of myocardial ischemia have their limitations. The commonly used 
evaluation techniques involve a 12-lead electrocardiogram (ECG) and cardiac markers 
such as troponins. A characteristic feature of ischemia is an elevation in the ST segment 
of the ECG. However, variations in ECG - ST segments produced by left ventricular 
hypertrophy, digitalis effect, and electrolyte abnormalities can mimic the ST segment 
changes of ischemia [59]. Cinca et al. [6] have recorded ST level elevation in electrodes 
overlying contiguous necrotic tissue, despite there being no ischemia of viable tissue in 
that region. Various bio-markers that are commonly used have their own limitations as 
well. Lactate dehydrogenase (LDH) is not specific to cardiac tissue whereas cardiac 
troponins are highly specific, but often very insensitive, requiring further testing to 
achieve an accurate diagnosis. All this further highlights the need for innovative methods 
of real time ischemia detection and monitoring. 
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1.2 BACKGROUND 
Electrical impedance measurements have been used for more than 80 years to 
determine passive electrical properties of several tissues, including kidneys, brain, liver 
and spleen [33, 47, 56, 57]. The impedance is monitored for variations shortly after death 
or removal of the organ from the animal. The measurement of myocardial electrical 
impedance thus allows an overall estimation of the passive electrical properties of cardiac 
tissue. 
It has been widely reported that the disruption of the plasma membrane is a 
characteristic feature of the final stage of hypoxic and ischemic necrotic cell death [23, 
24, 37, 38, 47]. Two approaches are commonly used to determine the time course of cell 
death in myocardial ischemia or hypoxia [47]. The first one is based on the ability of 
some dyes to enter or exit the cell only if sarcolemmal integrity is lost. Methods based on 
this approach allow the monitoring of necrotic cell death in cell preparations but not in 
intact myocardial tissues [15, 38]. The second approach detects the presence of large 
intracellular molecules (LDH and troponin) in the extracellular space [15, 41, 42, 46]. 
These molecules cannot leave the cell while the plasma membrane is intact. This 
approach cannot be used during severe ischemia when the extracellular space in 
inaccessible. 
Considerable research has been performed on the effects of ischemia on the 
electrical properties of myocardial tissue. The vast majority of literature focuses on 
changes of myocardial resistance or resistivity, rather than separating out the real and 
imaginary components of the electrical properties.  Jain et al. [27] have measured a 400% 
increase in baseline resistance at 1 kHz during 50 min of ischemia in isolated rat hearts. 
del Rio et al. [8] showed that the time to plateau onset in dogs was longer than in pigs 
and humans, but the resulting ischemic plateau values in dogs, pigs and humans were not 
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statistically different. Ivorra et al. [26] have made impedance and phase measurements on 
rat kidneys at 1 kHz. They have observed an impedance increase of 65% from the 
baseline value during 45 min of ischemia and a phase angle shift from -3.5° to -6.5° 
during the same period. Rodriguez-Sinovas et al. [46] have shown an increase in tissue 
resistivity from 150Ω-cm to 320Ω-cm during 45 min of ischemia in pig hearts. The 
resistivity returned to baseline within 15 min of reperfusion. The phase angle also shifted 
from -2° to -17° during the same period and returned to baseline almost immediately 
upon reperfusion. They made these measurements at a frequency of 7 kHz in both pig and 
isolated rat hearts. In rats, they report that ischemia induced a marked increase in 
myocardial resistivity (from 86.46±5.04 to 183.40±12.87Ω-cm at 45 min of ischemia) 
and a marked negative shift in phase angle (from -0.36±0.26 to -4.62±0.43 degrees). 
Cinca et al. [6] have shown that resistivity of one month old myocardial infarction at 1 
kHz was significantly lower than normal myocardium (110±30 vs. 235±60Ω-cm) in pig 
hearts. They also show that there is a marked increase in tissue resistivity in the acute 
ischemic region after 60 min of proximal occlusion of the LAD and virtually no change 
in resistivity in the center of the necrotic scar. 
 
1.2.1 Effects of Hypoxia on Tissue 
The cell volume of virtually every human cell is regulated by a Na+/K+ - ATPase, 
commonly known as the sodium potassium pump. In order to maintain the differential 
cell potential, cells must keep a low concentration of sodium ions and high levels of 
potassium ions within the cell. In the extracellular space, there are high concentrations of 
sodium and low concentrations of potassium, so diffusion occurs through ion channels in 
the plasma membrane. In order to keep the appropriate concentrations, the sodium-
potassium pump pumps sodium out and potassium in through active transport. Hypoxia 
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arising as a result of ischemia decreases the oxygen and hence the metabolic energy 
available to the cells, causing a failure of this active transport mechanism. As a result, the 
Na+ equilibrium is no longer regulated and an osmotic pressure imbalance develops 
between the intracellular and extracellular regions. The extracellular water penetrates into 
the cell with a subsequent cell swelling [13] and shrinkage of the extracellular region. 
This is manifested as a decrease in the electrical conductivity of the tissue at low 
frequencies [26]. 
Tissue necrosis caused by hypoxia is characterized by the breakdown of the 
structure and function of the plasma membranes of the hypoxic cells. The breakdown of 
the plasma membrane permeability barrier is preceded by a short metastable state that 
includes bleb formation, changes in lipid fluidity, and alterations in phospholipid 
composition [38, 47]. During this metastable state, blebs increase rapidly in size, trapped 
anionic fluorophores leak from the cytosol, onset of the mitochondrial permeability 
transition occurs, and lysosomes disintegrate [20, 23, 37, 38, 63]. The bleb finally 
ruptures and there is a rapid equilibrium of intracellular and extracellular contents [38]. 
Various high molecular weight intracellular proteins which were previously unable to 
leave the cell can now escape into the extracellular space. Such proteins include creatine 
phosphokinase (CPK), lactate dehydrogenase (LDH) and troponin which can all be used 
as biomarkers for cell necrosis. 
 
1.2.2 Myocardial Hibernation and Stunning 
Myocardial hibernation and stunning are two conditions caused by ischemia of 
cardiac tissue. Hibernation is defined as the reversible mechanical dysfunction of the 
heart during severe chronic ischemia [34]. Stunning, on the other hand, is the mechanical 
dysfunction that persists temporarily after reperfusion despite the absence of irreversible 
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damage and despite restoration of normal or near normal coronary flow [2, 3]. The 
underlying biochemical mechanisms for stunning are still largely unknown although a 
number of hypotheses were proposed in the 1980s, most of which have been 
subsequently abandoned [3]. Presently, the two viable theories regarding the pathogenesis 
of myocardial stunning are the oxyradical hypothesis (generation of oxygen-derived free 
radicals) and the calcium hypothesis (Ca2+ overload and decreased responsiveness of 
myofilaments to calcium) [3].  
The degree of myocardial dysfunction is one of the most potent predictors of 
future cardiovascular risk. Hence, it follows that the identification of stunned and/or 
hibernating myocardium can provide important information with regard to prognosis and 
clinical decision-making. 
 
1.2.3 Electrical Properties of Myocardial Tissue 
The major determinants of myocardial impedance are the extracellular and 
intracellular resistance, the gap junction conductance, and the cell membrane capacitance 
[6, 9, 19, 60]. Healthy myocardial tissue exhibits a marked frequency dependence in its 
impedance properties due to the high electrical permittivity of the cardiac muscle. Gabriel 
et al. [18] have suggested that the high permittivity most likely originates in the 
myocardial cellular trans-membrane charge distribution. 
Myocardial electrical admittance (Y) is defined as the sinusoidal current (I) 
applied through the tissue divided by the voltage (V) measured across it. Due to the 
capacitive properties of the cell membrane, the myocardial tissue is not purely resistive. 
This causes a time delay between the voltage and current waves that can be determined 
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from the phase angle of tissue admittance. The admittance (Y) is a complex number 
defined by 
jBGY +=          (1) 
mfCB π2=          (2) 
where G is the conductance (real part), B is the susceptance (imaginary part) and Cm is 
the muscle capacitance. Therefore, myocardial admittance can be precisely defined by 
two components: tissue admittance magnitude (|Y|) and phase angle (θ = tan-1B/G). If the 
myocardium is assumed to be a homogenous medium, an equivalent circuit model of the 
myocardium will comprise of the extracellular conductance in parallel with the cell 
membrane capacitance. The equivalent circuit is shown in Figure 1-1. Gm is the 
extracellular conductance and Cm is the cell membrane capacitance. 
 
 
Figure 1-1: Equivalent circuit model of the myocardium (homogenous) 
A more accurate approach is to model the myocardium as an inhomogeneous 
medium. The tissue can be considered as a combination of three main elements, namely 
the intracellular region, the extracellular region and the cell membranes. The intracellular 
and the extracellular conducting media are arranged in parallel and cell membranes act as 
an admittance (conductor and capacitor) connecting them. In this case, the equivalent 
circuit model will comprise of the extracellular conductance in parallel with a series 
combination of the intracellular conductance and the cell membrane capacitance. 
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Rodriguez-Sinovas et al. [47] have suggested that membrane rupture and colloid osmotic 
edema should reduce the total tissue resistance, considering the fact that both membrane 
rupture and colloid osmotic swelling have been suggested to occur almost simultaneously 
[38]. The equivalent circuit model for an inhomogenous medium is shown in Figure 1-2. 
Gi is the intracellular conductance. 
 
 
Figure 1-2: Equivalent circuit model of the myocardium (inhomogenous) 
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where I is the current (A), Q is the charge (C), A is the surface enclosing the source 
electrode (m2) and L is the path length for potential calculation, σm is the myocardial 
conductivity (S/m) and εm is the myocardial permittivity (F/m). It is assumed that both σm 
and εm are constants in the myocardium. Then, combining equation (3) with (4) yields the 
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Accordingly the myocardial conductance can be calculated from its capacitance in 
a fairly straightforward manner. 
Coronary occlusion causes a rise in the myocardial resistivity and this has been 
reported in various species [4, 5, 6, 7, 10, 28, 40]. This rise in resistivity is due to the 
increase in extracellular and intracellular resistance that leads to cell-to-cell electrical 
uncoupling [28]. Ischemia causes an accumulation of intracellular Ca2+ [6, 7], reduction 
of ATP content [6, 55] and accumulation of amphipathic lipid metabolites [6, 62] in the 
ischemic myocardium. All this causes an increase in gap junction resistance resulting in 
cellular uncoupling [6]. 
 
1.3 OBJECTIVES 
Myocardial stunning is reversible contractile dysfunction following a brief 
ischemic episode. This reversible nature is clinically significant and is in contrast to the 
irreversible myocardial dysfunction that occurs with necrosis. This dissertation aims to 
test the following hypothesis: 
 
Hypothesis: Measures of electrical admittance of myocardial tissue can distinguish 
between stunned and necrotic myocardium. 
Sub Hypothesis: The permittivity of the myocardium decreases when the tissue is 
ischemic. This is due to the changes in cellular composition and membrane injury that 
occurs during ischemia. The permittivity of muscle is much higher than other types of 
tissue like fat, skin and bone which makes the measurement of electrical admittance a 
good indicator of the pathological state of the muscle. 
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The first objective is to build and test an analog admittance measurement system 
to measure myocardial admittance. This system comprises of an admittance magnitude 
section and a phase measurement section. The magnitude circuit was developed by 
graduate students in our research group and has been described in detail by Fernandez 
[12]. My goal is to design and build an analog phase measurement system and integrate it 
with the admittance magnitude system to create a Real-time Admittance Measurement 
System – External Sensing (RamsES I). 
The second objective is to design a tetrapolar surface probe to measure 
myocardial admittance. The probe should have two outer electrodes delivering a constant 
current at a predetermined frequency and a pair of inner electrodes to measure admittance 
magnitude and phase angle. The electrode spacing determines the penetration depth of 
the electric field into the myocardium. The probe has to be sutured onto the epicardial 
surface and should only measure the admittance of the myocardial tissue and not blood in 
the left ventricle. Hence the electrical field penetration depth must not be greater than the 
ventricular wall thickness at diastole. 
The third objective is to test the system on rat models of ischemia and stunning. 
The Langendorff preparation of the isolated perfused rat heart model will be used for this 
study. Myocardial stunning will be induced by varying durations of global no flow 
ischemia, followed by various methods of reperfusion. The primary goal of this section is 
to correlate myocardial electrical admittance with the state of the myocardium. The 
surface probe will be sutured on the epicardial surface to measure the magnitude and 
phase angle of myocardial admittance during baseline, ischemia and reperfusion of the rat 
heart. Based on these measurements, the muscle conductivity and relative permittivity 
can be calculated. The main hypothesis is that the relative permittivity of the myocardium 
can be used to distinguish between normal, ischemic, stunned and necrotic myocardium. 
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These results will be compared with actual cardiac tissue damage information obtained 
by measuring the levels of lactate dehydrogenase (LDH) in the coronary effluent. LDH is 
commonly used in medicine as a marker of tissue breakdown. 
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CHAPTER 2 
Design and Development of a Real - Time Admittance Measurement 
System 
 
2.1 ADMITTANCE MAGNITUDE MEASUREMENT SYSTEM 
2.1.1 Design 
The admittance magnitude measurement instrument is based on the system 
developed by Feldman et al. [11] redesigned to work at a single frequency of 30 kHz and 
is illustrated in Fig. 2-1. The desired excitation frequency of 30 kHz was generated using 
a 4 MHz crystal and a digital counter chip (CD 4040, Texas Instruments Inc., Dallas TX) 
to divide the crystal frequency by a factor of 128. The counter output was converted into 
a sinusoidal current signal that was applied to the two outer electrodes, #1 and #4 in 
Figure 2-1. The instantaneous voltage signal between the inner electrodes, #2 and #3 in 
Figure 2-1, was amplified with an instrumentation amplifier (AD 624, Analog Devices, 
Norwood MA). The AD624 was chosen for its high speed (ft = 25 MHz), high common 
mode rejection ratio (CMRR = 85 dB) and low noise characteristics (4nV/√Hz). The 
signal was then actively rectified and filtered to remove the AC ripple. The constant DC 
voltage that is finally obtained is applied to a multiplier chip (AD 734, Analog Devices) 
whose output voltage is inversely proportional to the amplitude of the input signal and 
then scaled to + 10V to represent the conductance signal over the range of expected 
values. The output resolution of the magnitude measurement is 1mV/µS. 





Figure 2-1:  Block diagram of the admittance magnitude circuit 
 
2.1.2 Calibration 
Calibration of the conductance measurement device was accomplished with 1% 
metal film resistors between 200 Ω (5,000 µS) and 2.00 kΩ (500 µS).  The calibration 
resistors were tested on an Agilent Inc. Model 4194A Impedance / Gain-Phase Analyzer 
to ensure that no inductive or capacitive behavior was observable in them over the 
frequency range of interest, 1 to 100 kHz.  This curve is shown in Figure 2-2. The 
miniaturized tetrapolar catheter cable has substantial inter-wire capacitance: there are six 
inter-electrode parallel capacitances among the four lead wires [30]. The net effect of 
these capacitances was compensated by calibration of the catheter by immersing in a 
relatively large volume of saline of known electrical conductivity. The conductivity of 
the saline solutions was measured with a Hanna Model HI 8033 conductivity meter 
(Hanna Instruments, Woonsocket RI) with the temperature compensation turned off. A 
calibration curve was generated (for every catheter that was used) at the measurement 
frequency of 30 kHz to cover the range of expected effective conductivities for muscle 
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(2000 to 6000 µS/cm, or 0.2 to 0.6 S/m). These results are outlined in the following 
chapter. 
 

















Figure 2-2: Admittance magnitude calibration curve 
The conductance measurement exhibits excellent linearity for input conductance 
varying from 500 µS to 5000 µS as seen in Figure 2-2.  
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2.2 ANALOG PHASE MEASUREMENT SYSTEM 
I designed and developed a phase detection system using discrete analog 
components that determines the phase angle between two input sinusoidal signals. The 
system generates an output DC voltage that is proportional to the phase difference 
between the input signals. The functional units in the phase detection network are 
illustrated in the block diagram of Figure 2-3. 
 
2.2.1 System Overview 
The high pass filters are first order filters with a cut off frequency of 33 Hz. They 
are used to eliminate any DC offset in the input signals. The high-speed comparators (LM 
339, National Semiconductor Corp., Santa Clara CA) are used as zero crossing detectors 
and generate output square pulses varying from 0V to +5V with a duty cycle of 50%. 
These pulses are applied to the input of a NAND gate (CD 4011, Texas Instruments Inc., 
Dallas TX). The output of the NAND gate is a series of pulses whose duty cycle is 
proportional to the phase difference between the two input signals. A true RMS to DC 
converter chip (AD536, Analog Devices, Norwood MA) is used to obtain a DC voltage 
proportional to the duty cycle of the NAND gate output pulses. The low pass filter is a 
first order filter with a cut off frequency of 160 Hz and is used to remove any high 
frequency noise from the output of the true RMS chip. The gain and offset circuitry will 
enable the DC output of the circuit to vary from -9V to +9V for input phase angles 
varying from -90˚ to +90˚. The phase lag/lead circuit is essentially comprised of a D-type 
flip-flop whose input and clock are connected to the two comparator outputs. The output 
of the flop will be either 0V or +5V depending on whether the sine wave in channel 1 
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leads (+5V output) or lags (0V output) the wave in channel 2. This flop output is used to 
set the polarity of the final DC output of the system. 
 
 
Figure 2-3: Block diagram of the analog phase system 
The phase circuit has a sensitivity of 100 mV/degree. The measured phase angle 
is corrected to remove catheter and measurement system phase shift effects by making 
phase angle measurements using the same catheter in saline of known conductivity. Since 
the phase shift in saline has to be zero degrees, any measured phase shift is the effect of 
the catheter and the measurement system. For small phase angles (0 to 5˚), there is a non-
linearity in the DC voltage output of the system. This does not affect the measurements 
since the phase from the catheter and measurement system is between 30 and 35 degrees, 
ensuring that the system never has to differentiate between phase angles smaller than 5 
degrees. 
 
2.2.2 Circuit Diagrams 
The first stage includes high pass filters, comparators and the CMOS NAND gate, 




Figure 2-4: Circuit diagram of the first stage of the analog phase system 
 
The high pass filters are passive first order filters with a cut off frequency of 33 
Hz. The high speed comparators (LM211) convert the input sinusoidal signals into square 
waves which are applied to the two inputs of a CMOS NAND gate (CD4011). The 
NAND gate output is a 50% duty cycle square wave if the input signals to channels 1 and 
2 are in phase. This duty cycle increases to 100% as the phase angle between the input 
channels increases to 180°. This is illustrated in Figures 2-5 and 2-6.  
A more efficient implementation would have been to use an XOR gate instead of 
a NAND gate, since the square wave output duty cycle of the XOR gate would vary from 
0% to 100% corresponding to input phase angles of 0° and 180° respectively. However, 
when the XOR gate is used in combination with the true RMS to DC chip, the output is 
non linear for small values of phase angle when the duty cycle has to increase from zero 








Figure 2-6: Example waveforms for 30 degree phase shift 
The second stage includes the true RMS to DC conversion circuit, low pass filter 
and a gain and offset adjust circuit. The NAND output from the first stage is connected to 
the input of the true RMS to DC chip (AD536). The output of this circuit is a DC voltage 
level dependent on the duty cycle of the NAND output. The following low pass filter has 
a cut off frequency of 160 Hz to remove high frequency noise spikes from the DC output. 
The gain circuit consists of a summing amplifier that adds an offset voltage to the AD536 
output so that a phase angle of 0° corresponds to 0V and a phase angle of 90° 
corresponds to +9V. The offset voltage is adjustable to calibrate out the phase effects of 
the instrumentation. The final output of this stage is a DC voltage ranging from 0 to +9V 
for phase angles varying from -90° to +90°. This stage cannot distinguish between 




Figure 2-7: Circuit diagram of the second stage of the analog phase system 
The final stage consists of the phase lag/lead detect circuit. This is accomplished 
using a D-type flip-flop whose input and clock are connected to the two comparator 
outputs. The output of the flop will be either 0V or +5V depending on whether the sine 
wave in channel 1 leads or lags the wave in channel 2. This flop output is used as one of 
the control signals of an analog switch (MAX4535) that routes the DC phase signal 
through either a buffer or a buffer and a unity gain inverting amplifier that inverts the 
polarity of the DC signal. Hence the final DC output of the system varies from -9V to 
+9V for phase angles varying from -90° to +90°. The final output is also scaled down by 
a factor of 100 and connected to an LCD panel meter to display the phase angle in 




Figure 2-8: Circuit diagram of the third stage of the analog phase system 
 
2.2.3 System Noise and Resolution 
The noise analysis of the phase system was performed by taking a large number 
of measurements at a constant input phase difference of ten degrees. The probability 
density function (PDF) of approximately 3,500 output samples was acquired using an 
ADInstruments Powerlab data acquisition system and plotted as shown in Figure 2-9.  
The noise is extremely low, ±0.05 degrees. The PDF of the distribution is very 
close to a Gaussian distribution and the noise has a variance of 0.006 degrees. 
A simple method to estimate resolution is to measure the peak-to-peak variations 
resulting with a fixed input, as shown in Figure 2.9.  Given this definition, the phase 
resolution is 0.1° because the typical variations are ±0.05°. 
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Figure 2-9: PDF with a constant input of 10 degrees 
The system resolution was also determined by acquiring data for several closely 
spaced phase offsets. A Students-T test was performed for various numbers of samples. 
The PDF of several phase offsets is shown in Figure 2-10 where each PDF was calculated 
using approximately 3,500 samples. 
 



















Figure 2-10: PDF for several closely spaced phase inputs 
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To use the t-statistic, one assumes the errors are normally distributed (with equal 
variances), and the errors are independent within each group and between the groups. 
Phase data is first collected for φ =10.0046°. Then, the phase is changed and phase data is 
collected again. The null hypothesis is that the means of two normally distributed 
populations are equal (meaning the instrument cannot resolve the change). For a sample 
size of 20, the t-statistic must be greater than 2.1 for a 95% confidence interval to reject 
the null hypothesis (meaning the instrument can resolve the change). Table 2-1 shows the 
calculated t-statistic for various numbers of samples. From the table, it is seen that the 
resolution for a sample size of 20 is about 0.03° (since the t-statistic between φ = 
10.0046° and φ = 10.0304° is greater than 2.1). This value is slightly smaller than the 




φ=10.0106° φ=10.0138° φ=10.0249° φ=10.0302° 
20 0.63 2.52 0.08 4.69 
100 1.80 0.40 5.76 12.25 
200 3.13 1.69 9.75 17.07 
Table 2-1: t-statistic values for various numbers of samples, taken between φ=10.0046° 
and the other four. 
 
2.2.4 System Accuracy 
The phase accuracy of the system was determined by applying sinusoidal signals 
with a known phase difference at the input and measuring the system output. The input 
phase difference was calculated using an oscilloscope. The measurements were made at 2 
kHz and 30 kHz and the results are shown in Figures 2-11 and 2-12.  
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Actual vs Measured phase (2 kHz)




































Figure 2-11: Actual phase vs. measured phase at 2 kHz 
Actual vs Measured phase (30 kHz)




































Figure 2-12: Actual phase vs. measured phase at 30 kHz 
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It is evident from the above graphs that the instrument is linear over all regions 
analyzed for both 2 kHz and 30 kHz signals. In both cases the correlation coefficient, R2, 
is 0.9998. Absolute error was then calculated as the absolute value of the difference 






























Figure 2-13: Actual phase vs. Error at 2 kHz and 30 kHz 
 
It should be noted that this error is due to both error in the instrument and the 
error in the estimation of the actual input phase angle. Previous estimates of phase angle 
in the mouse myocardium using digital signal processing of the excitation and measured 
signals have shown phase angles between 5 and 30 degrees [29]. The instrumentation to 
measure admittance magnitude will induce a phase offset of about 10 degrees (at 30 kHz) 
from the band pass filters used in the circuit and the inter-wire capacitances in the surface 
probe. 
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2.3 REAL-TIME ADMITTANCE MEASUREMENT SYSTEM 
The admittance magnitude and phase measurement systems described earlier are 
combined into a single integrated system. The block diagram of the new system is shown 
in Figure 2-14.  
 
 
Figure 2-14: Instrument used to measure complex admittance 
 The RamsES I system has two BNC analog output channels, one each for the 
magnitude and the phase angle. These two parameters are also displayed on two LCD 
panel meters located on the front panel of the instrument. The system is designed to work 
over an admittance magnitude range of 500µS to 5000µS and phase angle range of -90° 
to +90°, which covers the range of values measured in the myocardium as well as in the 
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LV blood pool. A calibration switch is used to switch between the internal conductance 
calibrator and the external catheter. The catheter is plugged in via a six pin RedelTM 
connector (LEMO connectors). The system is powered using an external low-noise plug-
in power supply manufactured by Stancor Electronic (Star-9007). The supply provides up 
to 1A at 5V and 300mA at ±12V. The RamsES I circuit draws approximately 100mA 
from the ±12V supply and about 20mA from the 5V supply, which is well within the 
limits of the power supply. 
 
 








Design and Development of Tetrapolar Admittance Catheter 
3.1 OVERVIEW 
The use of tetrapolar electrode configuration for admittance measurements and its 
advantages over the bipolar electrode configuration have been described elsewhere [51, 
54]. Briefly, the tetrapolar configuration is preferred since it compensates for the 
electrode-electrolyte interface impedances. In a linear tetrapolar electrode configuration, 
a constant current is injected through the outer electrode pair and the voltage difference 
between the inner electrode pair is measured. Since the current is kept constant, Ohms 
law dictates that any change in the measured voltage corresponds to a change in the 
admittance between the inner electrode pair. 
 
 
Figure 3-1: Surface probe used for admittance measurements 
Myocardial tissue is highly anisotropic due to the complex structure of fiber 
orientation. There is a change in fiber orientation by over 120° between epicardium and 
endocardium. This anisotropy of the myocardial tissue makes it necessary to use a surface 
probe that has a depth of penetration approximately equal to the thickness of the 
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myocardium to ensure that the admittance measurements are isotropic. The field 
penetration depth is directly proportional to the electrode spacing on the probe.  
 
3.2 ELECTRIC FIELD PENETRATION DEPTH 
The experimental technique to determine the field penetration depth of tetrapolar 
surface admittance catheters is described by Kottam et al. [31]. Briefly, the experimental 
setup consists of a flat bottomed dish filled with saline with a movable plastic sheet at the 
bottom. The position of the movable sheet could be accurately adjusted by means of a 
micro manipulator with a resolution of 0.1 mm. The admittance catheter was placed on 
the saline surface and the plastic sheet was moved closer to the catheter. The admittance 
magnitude was monitored continuously and the depth of penetration was determined to 
be the spacing between the catheter and the plastic sheet that caused the admittance 
magnitude to drop to ninety percent of the magnitude when the plastic sheet is at the 
bottom of the dish (i.e. |Y|inf ). The experimental setup is shown in Figure 3-2.   
 
 
Figure 3-2: Experimental setup to measure field penetration depth of surface catheters 
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The measured depth of penetration was verified using finite element models 
developed using a commercially available software package (COMSOL). The simulation 
results were compared with the actual in vitro experimental results in saline of known 
conductivities. This also enabled the estimation of the probe constant Kp for the different 
catheter designs. The models indicate that the effective penetration depth increases as the 
spacing between the sensing electrodes (#2 and #3) is increased. If this spacing is kept 
constant, the effective penetration depth is affected by the spacing between the 
stimulation and the sense electrodes. This is because the field geometry is determined 
only by the spacing between the two outer stimulation electrodes (#1 and #4) and the 
penetration depth decreases as this spacing is decreased. The results are summarized in 
Table 3-1. The calculated penetration depths were also independent of the conductivity of 
the bulk medium in the models. 
 
Electrode Spacing (mm) 
1-2 2-3 3-4 
Calculated field 
penetration depth (mm) 
0.75 1.6 0.75 1.73 
0.75 2.2 0.75 1.93 
0.75 2.0 0.75 1.87 
0.5 2.0 0.5 1.41 
0.5 1.8 0.5 1.33 
Table 3-1: Electric field penetration for various electrode spacing (COMSOL results) 
The current density over the electrode surface is not uniform, but is denser around 
the edges of the electrode. Using a constant current boundary condition at the electrodes 
will force the current density to be uniform over the entire electrode surface in the model. 
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To overcome this, I specified the stimulation electrodes as constant potential electrodes 
with an excitation voltage of ±1.5V at 31.25 kHz. The electric field distribution for a 
tetrapolar electrode configuration with constant voltages of ±1.5V applied between the 
outer electrodes is shown in Figure 3-3. In this case, the bulk medium is assumed to be 
isotropic with a conductivity of 2000 µS/cm. 
 
Figure 3-3: COMSOL simulation results for electric field distribution for tetrapolar 
electrode configuration 
The admittance was measured between electrodes 2 and 3 for different distances 
of the bottom insulating layer from the tetrapolar electrode surface. The distance was 
decreased from 5mm down to 0.5mm and the distance at which the measured admittance 
dropped to 90% of the value at 5mm was considered as the effective penetration depth. 
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3.3 TETRAPOLAR SURFACE PROBE 
I designed and built a tetrapolar admittance probe that can be sutured onto the 
epicardial surface of the left ventricle of rat hearts. This probe is used to measure 
localized myocardial admittance during baseline, varying durations of ischemia and 
reperfusion. The surface probe is comprised of four linear electrodes mounted on a 
polystyrene strip. The electrodes are made from 0.4 mm diameter solid gold wire (Cooner 
Wire, part no. CW 5263-26). The electrode spacing is illustrated in Figure 3-1.  
The electrodes were attached to the polystyrene strip using fast acting 
cyanoacrylate glue. The other ends of the gold wires were connected to a four pin Molex 
header connector. The entire catheter and connector assembly is shown in Figure 3-5. 
 
 
Figure 3-4: Epicardial surface probe used for admittance measurements 
 
 
Figure 3-5: Epicardial surface probe and connector 
The electric field penetration depth of this probe was determined experimentally 
using the technique described above. Two different saline solutions with conductivities of 
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10,500µS/cm and 1,850µS/cm were used to ensure that the measurement results were 
independent of the saline conductivity. The measurement results for one of the probes are 
shown in Figures 3-6 and 3-7. The field penetration depth was calculated to be 1.6mm in 
both cases. The COMSOL simulation results show a field penetration depth of 1.87mm 
for the same electrode spacing. This is because the COMSOL models are in 2D and 
assume an infinite electrode length along the third dimension. In reality, the finite 
electrode length causes the field lines to constrict around the ends of the electrode. Thus 
the model tends to overestimate the field penetration depths when compared with the 
experimental results. 
The left ventricular wall thickness of rats ranges from 1.6 – 2.0 mm for body 
weights ranging from 200 to 300 grams [39]. I built and characterized a total of three 
surface probes with differing electrode spacing. The measured and calculated field 
penetration depths for all three probes are shown in Table 3-2. 
 
Electrode Spacing (mm) Penetration Depth (mm) Probe 
# 1-2 2-3 3-4 Experimental Calculated 
6 0.75 2.0 0.75 1.60 1.87 
7 0.50 1.8 0.50 1.15 1.33 
8 0.75 1.6 0.75 1.47 1.73 
Table 3-2: Measured vs. theoretical field penetration results for three surface probes 
From the above table, it is evident that probe #6 the optimal choice for the 
myocardial properties measurement (field penetration depth almost equal to LV wall 
thickness). The length of the probe must also enable all four electrodes to be in contact 








































Figure 3-7: Field penetration results for σ = 1,850µS/cm 
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3.4 DETERMINATION OF PROBE CONSTANT 
The probe constant K is defined as the ratio between the actual conductivity (σ) of 
the medium and the conductance (G) measured by the probe. Its value depends on the 
relative spacing of the electrodes on the probe which affect the field geometry. 
GK ×=σ          (6) 
In terms of the permittivity of the medium (εm) and the capacitance (C) measured 
by the probe, 
CKm ×=ε          (7) 
From equation 3 described in chapter 1, the probe constant K can be related to the 














       (8) 
 
The probe constant was determined by making conductance measurements on 
saline of known conductivities. These calibration solutions were prepared by mixing 
calculated amounts of sodium chloride in distilled water. Six different calibration 
solutions with conductivities of 2000, 4000, 6000, 8000, 10000 and 12000µS/cm were 
prepared and the conductivities were verified using a commercially available 
conductivity meter (Hanna Instruments) with the temperature compensation turned off.  
The known conductivities were plotted on the x axis and the measured admittance 
magnitudes were plotted on the y axis. This graph is shown in Figure 3-8. The probe 
constant K is calculated by taking the reciprocal of the slope of the line. For the probe 































Myocardial Ischemia and Stunning in the Isolated Rat Heart 
4.1 OVERVIEW 
The most prevalent experimental model to study myocardial ischemia and 
stunning is the Langendorff preparation of isolated perfused heart. The Langendorff 
model has been used in cardiovascular research for over 40 years [22] and provides a 
highly reproducible model that can be studied quickly and in large numbers at low cost. 
The effects of myocardial ischemia can be studied more easily under controlled 
conditions in isolated models.  
The isolated heart can be perfused in either constant flow or constant pressure 
mode. Constant flow perfusion adds an additional element of constancy to the experiment 
and simplifies the analysis of experimental data. The disadvantage here is that unlike in a 
constant pressure system, autoregulatory mechanisms are overridden and the system does 
not automatically alter the amount of perfusate delivered to the whole heart when there 
are changes in heart rate or load or when regional ischemia is imposed [22]. In spite of 
this disadvantage, it is experimentally preferable to control flow rate and heart rate since 
these variables can influence other indices of mechanical function. I used a constant flow, 
non recirculating model (Radnoti Glass Technologies Inc.) for the ischemia/stunning 
studies. The system is shown in Figure 4-1. 
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Figure 4-1: Constant flow, non recirculating Langendorff system 
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The system uses a water-jacketed 2-liter reservoir (A) to maintain and oxygenate 
the perfusate solution. A peristaltic pump draws perfusate from the reservoir and drives 
the solution up to a water-jacketed bubble trap (C) via a water jacketed flex tube 
assembly (B), where bubbles are removed from the flow, and then down to the aortic 
cannula into the heart chamber via a second water jacketed flex tube assembly (D). 
Effluent from the heart can be collected for evaluation. The constant flow peristaltic 
pump is adjustable with flow rates ranging from 1-10 ml/min. A pump-driven circulating 
water bath is used to circulate warm water through the water jackets on the tubes and 
glass reservoirs for excellent temperature control of the buffer. Myocardial stunning is 
induced in this model by 15 min of global no-flow ischemia. 
The temperature of the myocardial surface must be monitored and regulated since 
conductance is a function of the temperature of the tissue. This was achieved by 
maintaining the perfusate at 36°C and placing the isolated heart in a water jacketed 
temperature regulated heart chamber (E). The relation between temperature and 
conductivity is given by 
( )[ ]00 exp ttt −= ασσ         (9) 
where σt is the conductivity at temperature t, σ0 is the conductivity at temperature t0 and α 
is the temperature coefficient of conductivity (0.021 ºC-1 for NaCl). 
The perfusion fluid that is most commonly used in Langendorff studies is the 
Krebs-Henseleit bicarbonate buffer. This fluid mimics the key ionic content of blood and 
plasma and has a pH of 7.4 at 37°C. The effluent from the heart can be collected at 





4.2 LANGENDORFF SYSTEM SETUP 
The various steps involved in setting up the constant flow, non recirculating 
Langendorff system are outlined below. 
• Circulate distilled water through perfusate channels for 15 min to flush out the 
system. 
• Insert Millar pressure transducer above the aortic cannula (pressure should be 50-100 
mmHg). 
• Run the water bath at ~42°C and circulate the warm water through the water jacket 
tubes. Verify that the temperature of liquid in perfusate channels is 37°C. 
• Adjust perfusate flow rate to 10 ml/min. 
• Attach LV balloon to the end of the fluid filled LV catheter, taking care to remove 
any trapped air bubbles. 
• Prepare Krebs-Henseleit (KH) bicarbonate buffer by mixing the following amounts of 
salts in 1 litre of water. The calcium should be added at the very end after ensuring 
that the perfusion solution has a pH of 7.40. 
o NaCl (118.5mM)  - 6.900 gms 
o NaHCO3 (25mM)  - 2.100 gms 
o KCl (4.7mM)   - 0.350 gms 
o MgSO4 (1.2mM)  - 0.296 gms 
o KH2PO4 (1.2mM)  - 0.163 gms 
o glucose (11.0mM)  - 1.982 gms 
o CaCl2 (1.4mM)  - 0.155 gms 
 
• If the pH is greater than 7.40, add a few drops of hydrochloric acid to reduce the pH. 
• Pour into the buffer into the perfusate container of the Langendorff system. 
 42 
• The buffer will be saturated with gas (95%O2 / 5%CO2) through a bubbler inserted 
into the perfusate container. 
 
4.3 ISOLATED HEART PREPARATION 
The isolated heart studies were done on adult male WKY rats weighing between 
210 and 300gms. The protocol that was used for the ischemia and the stunning studies is 
outlined below. 
• Weigh the rat after it is anesthetized using the standard rat cocktail. 
• Rapidly excise the heart via anterior thoracotomy and place in ice-cold (4°C) beaker 
of Krebs-Henseleit (KH) bicarbonate buffer to arrest the heart. 
• Perform aortic cannulation rapidly (within 60 seconds) and perfuse the hearts with 
KH buffer in Langendorff mode at a flow rate of 10 ml/min. 
• Remove left atrial appendage to provide a clear field of view. 
• Insert a deflated balloon into the LV via the mitral valve. This balloon is attached to a 
short rigid catheter and a Millar pressure transducer. 
• Inflate the balloon with water from a micro syringe until an LVEDP of between 4 and 
8 mmHg is obtained. 
• Position the tetrapolar surface probe on the epicardial surface, above the LV. Monitor 
admittance magnitude and phase angle continuously using the RamsES I unit. 
• Throughout the experiment the heart will be placed in a water-jacketed chamber (E) 
to maintain constant temperature during the ischemic period. 
• Monitor aortic pressure throughout the working heart model perfusion periods in the 
aortic outflow line with a Millar transducer. 
• Allow the isolated heart preparation to stabilize for about 10 min. 
• Collect baseline perfusate samples. 
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4.3.1 Control Hearts Protocol 
• The isolated heart system is setup as described above. 
• Hang the heart and perfuse for 140 min. 
• Draw perfusate samples at three, five and ten minute intervals during perfusion. 
• Analyze the samples for markers of ischemia (LDH). 
• Weigh the heart, make slices along the short axis and store the slices in formalin for 
histologic analysis. 
 
4.3.2 Myocardial Ischemia Protocol 
• The isolated heart system is setup as described above. 
• Induce global no-flow ischemia by stopping aortic perfusion for 90 min. 
• Reperfuse for 20 min by reestablishing aortic perfusion. 
• Draw perfusate samples at five minute intervals. 
• Analyze the samples for markers of ischemia (LDH). 
• Weigh the heart, make slices along the short axis and store the slices in formalin for 
histologic analysis. 
 
4.3.3 Myocardial Stunning Protocol 
• The isolated heart system is setup as described above. 
• Induce global no-flow ischemia by stopping aortic perfusion for 15 min. 
• Reperfuse for 90 min by re-establishing aortic perfusion. 
• Draw perfusate samples at three, five and ten minute intervals during reperfusion. 
• Analyze the samples for markers of ischemia (LDH). 
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4.4 CONTROL HEARTS RESULTS 
Three adult male WKY rat hearts were perfused in constant flow Langendorff 
mode according to the protocol described in the earlier section. The measured admittance 
magnitude and phase angle was used to determine the relative permittivity and 
conductivity of the myocardial tissue over a perfusion duration of 140 min. LDH samples 
were also collected at regular intervals to determine the extent of myocardial cell damage, 
if any. These hearts served as controls and the results were compared with similar results 
from hearts subject to the stunning and ischemia protocols. 
The LV pressure was monitored by inserting a fluid filled balloon into the LV. 
The pressure in the balloon was measured using a 1.4 Fr. Millar pressure sensor and was 
zeroed prior to insertion into the LV. After insertion, the balloon was inflated/deflated to 
obtain a left ventricular end diastolic pressure (LVEDP) between 4 and 8 mmHg. The 
LVEDP increased steadily from 2.7 to 20.6 mmHg within the first 15 minutes of hanging 
the heart and perfusing it. The diastolic pressure then gradually dropped to 19 mmHg 
over the next 45 minutes and then remained fairly constant over the remainder of the 
perfusion duration. This is illustrated in Figure 4-2. The error bars represent the standard 
deviation of the measurements over three different control hearts. 
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Figure 4-2: Measured LVEDP during 140 min of perfusion 
The overall health of the heart was determined by monitoring the developed 
ventricular pressure. The developed pressure is defined as the difference between the 
systolic and diastolic pressure. The control hearts developed an average pressure of 77 
mmHg during the initial period of perfusion. Thereafter, the average developed pressures 
started to drop gradually indicating that the hearts were slowly dying from the stress of 
being removed from the body and artificially perfused. At the end of the 140 minute 
perfusion period, the developed pressure had dropped from 77 to 30 mmHg. The 
temperature of the heart and the perfusate were measured at regular intervals using a 
thermistor based temperature probe (that was built and calibrated in Dr. Valvano’s lab) 
and verified to be 37°C at all times during the experiment. The average developed 
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pressures in the control hearts are shown in Figure 4-3. The error bars represent the 
standard deviation of the measurements over three different hearts. 
 



































Figure 4-3: Developed pressure during 140 min of perfusion 
The heart rate was calculated from the LV pressure measurements as an 
alternative indicator of the overall health of the heart. The control hearts start out with an 
average heart rate of 260 beats per minute and the rate gradually increases to over 300 
beats per minute at the end of the perfusion duration. This instability in the heart rate is 
because in vivo, the atria and the SA node are not perfused by coronary vessels but by 
extracardiac vessels, which are severed when the heart is excised for perfusion [22]. 
Hence the affected tissue is dependent on superfusion by the coronary effluent flowing 
out of the right atrium for its oxygen, nutrients and temperature control. The variation of 
the heart rate with time is shown in Figure 4-4. 
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Figure 4-4: Average heart rate during 140 min of perfusion 
The large standard deviations in the heart rate can be eliminated if the hearts are 
externally paced. However, external pacing would interfere with the electrical admittance 
measurements. On examining each of the hearts individually, it is seen that two of the 
three control hearts exhibit a marked increase in heart rate over the entire perfusion 
duration. The third heart exhibited an unusual drop in heart rate for 60 minutes during the 
perfusion interval, the cause of which is unknown. This is illustrated in Figure 4-5. 
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Figure 4-5: Heart rate of three control hearts during 140 min of perfusion 
 
4.4.1 Relative Permittivity and Conductivity of Myocardium 
The admittance magnitude |Y|, phase angle θ and left ventricular developed 
pressure were monitored in real time during the entire 140 minute perfusion duration. The 
values of |Y| and θ were used to calculate the relative permittivity (εr = K.C, after probe 
capacitance is removed) and conductivity (σ = K.G) of the myocardium based on the 
measured probe constant K (described by equations 6, 7 and 8 in section 3.4). These 
results are shown in Figures 4-6 and 4-7. 
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Figure 4-6: Relative permittivity of myocardium (at 30 kHz) in control hearts 
The average permittivity starts out at 15,000 and decreases to 10,000 over the first 
15 minutes after which it remains fairly constant over the next 80 minutes. The average 
permittivity then rises to 12,500 and remains at that value for the remainder of the 
perfusion duration.  
The average value of myocardial conductivity is 0.75 S/m (7500 µS/cm) when the 
heart is initially perfused. The conductivity slowly rises to about 1.0 S/m (10000 µS/cm) 
during the first 50 minutes and remains at that value over the remainder of the perfusion 
duration. This trend along with the standard deviations is illustrated in Figure 4-7. 
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Figure 4-7: Electrical conductivity in control hearts 
 
4.4.2 LDH Analysis of Coronary Effluent 
Samples of the coronary effluent were collected during perfusion to determine the 
relative amount of LDH release. The samples were analyzed using a commercially 
available LDH cytotoxicity kit (Cayman Chemicals). The kit consisted of 100 µL each of 
NAD+, Lactic Acid and INT (tetrazolium salt), 15 mL of assay buffer and one vial each 
of LDH standard and diaphorase. The diaphorase was reconstituted with 150 µL of the 
assay buffer. Following this, the reaction solution was prepared by mixing 100 µL each 
of NAD+, Lactic Acid, INT and reconstituted diaphorase with 9.6 mL of assay buffer. 
When equal amounts of the reaction solution and the coronary effluent samples are mixed 
together, the following coupled two-step reaction occurs. In the first step, LDH catalyzes 
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the reduction of NAD+ to NADH and H+ by oxidation of lactate to pyruvate. In the 
second step of the reaction, diaphorase uses the newly formed NADH and H+ to catalyze 
the reduction of INT to highly colored formazan, which absorbs light of wavelength 490-
520 nm. The amount of formazan formed is proportional to the amount of LDH present in 
the coronary effluent. LDH standard solutions were prepared by adding 1.8 mL of the 
assay buffer to the vial containing the LDH standard. The concentration of this standard 
is 200 mU/mL. One unit (U) is the amount of enzyme that catalyzes the reaction of 1 
µmol of substrate per minute. This standard solution can be diluted in differing amounts 
of the assay buffer to obtain desired concentrations of standard solutions. A 
spectrophotometer was used to determine the absorbance of the effluent samples and the 
standards at 490 nm. The LDH level in the sample was determined by comparing the 
absorbance of the sample with the absorbance of the known standards. 
The results show that the highest concentration of LDH is present in the samples 
collected within the first 10 minutes. This is to be expected, since the process of 
removing the heart from the animal, cannulating the aorta and inserting the ventricular 
balloon all cause some tissue death. The subsequent samples contain decreasing amounts 
of this intracellular protein, as seen in Tables 4-1 and 4-2. The concentration of LDH in 
the sample is expressed in terms of µU/ml. 
  




0 5 10 15 20 25 30 35 40 45 50 
1 400 138 325 342 396 413 200 129 0 83 46 
2 2208 1308 1300 1317 1275 733 717 550 429 308 283 




59 64 74 84 94 104 114 124 134 144 
1 33 8 13 13 8 17 4 0 0 4 
2 258 238 217 175 133 163 192 171 150 400 
3 1958 1642 1325 1117 908 775 642 542 442 425 
Table 4-2: LDH concentration in control hearts (59 min to 144 min) 
The LDH analysis of the control hearts shows that rat 1 exhibits the least amount 
of LDH release and should therefore be considered the best control. Rat 3 has a high and 
sustained LDH release for over 85 minutes and is the worst of the three controls. Rat 3 
also exhibited an unusual drop in heart rate for 60 minutes during the perfusion interval, 
which was illustrated in Figure 4-5. The average change in LDH release from baseline 
(time = 0) for the three control hearts is shown in Figure 4-8.  
 



































Figure 4-8: Average change in LDH release for the control hearts 
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4.5 MYOCARDIAL ISCHEMIA RESULTS 
Eight adult male WKY rat hearts were subject to 90 min of global no-flow 
ischemia according to the protocol described in the earlier section. The measured 
admittance magnitude and phase angle were used to determine the relative permittivity 
and conductivity of the myocardial tissue during baseline, ischemia and reperfusion. 
LDH samples were collected during baseline and reperfusion to investigate the incidence 
of the cell plasma membrane damage due to ischemia. 
The LV pressure was monitored in the same manner as in the control heart 
protocol, by inserting a balloon into the LV. The LVEDP dropped to zero within the first 
minute of occlusion and then gradually increased to about 5 mmHg over the next 30 min 
of occlusion. This was followed by a 10-15 min period where the LVEDP increased 
rapidly from 5 to 15 mmHg, indicating diastolic dysfunction as a result of calcium 
overload within the cells. The pressure then gradually drops by about 2 mmHg over the 
next 30 min. On reperfusion, the LVEDP increases to nearly 100 mmHg indicating total 
diastolic failure. 
The measured LVEDP during baseline and the 90 min occlusion period is shown 
in Figure 4-9. The error bars represent the standard deviation of the measurements over 
seven different hearts. 
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 Figure 4-9: Measured LVEDP during 90 min of occlusion 
 
4.5.1 Relative Permittivity and Conductivity of Myocardium 
The admittance magnitude, phase angle and left ventricular developed pressure 
were monitored in real time during baseline, occlusion and reperfusion. The measured 
admittance magnitude and phase angles were then used to calculate the relative 
permittivity (εr) and conductivity (σ) of the myocardium. These results are summarized in 
Tables 4-3 and 4-4 for baseline and at specific times during occlusion. The occlusion was 







-0.6 0.1 1.1 5 10 20 30 
1 13587 12555 10183 10498 9396 8344 8595 
2 12263 12840 13329 12950 12686 12095 12102 
3 9670 9616 11461 11710 11304 10943 11491 
4 3942 4047 3423 4528 4849 5240 6620 
5 17317 17219 14869 13621 13169 12333 11627 
6 7818 6470 6068 9204 8943 8450 8871 
7 11633 11374 11295 9746 8751 7914 7498 
Mean 10890 10589 10090 10322 9871 9331 9543 




40 50 60 70 80 90  
1 10804 13003 14229 14285 13606 13061  
2 11557 13838 15543 13059 11400 15409  
3 14690 13929 12393 11961 12347 12103  
4 8885 10622 12974 14009 14164 13908  
5 10847 11619 12445 15300 16925 16468  
6 9596 11361 13182 13870 13812 13634  
7 9230 12940 12765 12398 12145 11599  
Mean 10801 12473 13362 13555 13486 13740  
Std. Dev 1970 1283 1142 1155 1819 1732  

















































Figure 4-10: Relative permittivity of myocardium during baseline and 90 min of 
occlusion 
It is seen that the average εr is about 11,000 during baseline. After occlusion, εr 
drops gradually by about 15% for the first 20 minutes. This is followed by a 10 minute 
period where εr gradually increases by about 2% following which there is a 30 minute 
period where εr increases rapidly by nearly 40% to a value of 13,400. After this, the 
relative permittivity remains fairly constant until reperfusion. This trend along with the 









-0.6 0.1 1.1 5 10 20 30 
1 0.488 0.448 0.490 0.447 0.264 0.231 0.221 
2 0.558 0.520 0.438 0.372 0.344 0.308 0.272 
3 0.552 0.491 0.366 0.292 0.269 0.246 0.223 
4 0.711 0.667 0.623 0.509 0.470 0.451 0.441 
5 0.394 0.404 0.396 0.396 0.379 0.382 0.382 
6 0.608 0.656 0.222 0.307 0.293 0.291 0.289 
7 0.348 0.435 0.256 0.190 0.173 0.159 0.153 
Mean 0.523 0.517 0.399 0.359 0.313 0.296 0.283 




40 50 60 70 80 90  
1 0.217 0.222 0.227 0.233 0.228 0.224  
2 0.246 0.238 0.235 0.265 0.313 0.235  
3 0.194 0.198 0.228 0.271 0.256 0.245  
4 0.231 0.228 0.284 0.312 0.321 0.323  
5 0.367 0.275 0.288 0.423 0.479 0.531  
6 0.240 0.224 0.226 0.227 0.228 0.232  
7 0.151 0.190 0.205 0.213 0.213 0.205  
Mean 0.235 0.225 0.242 0.278 0.291 0.285  
Std. Dev 0.067 0.028 0.032 0.072 0.093 0.115  
Table 4-4: Electrical conductivity of myocardium during baseline and 90 min of 
occlusion 
 
The average value of myocardial conductivity is 0.52 S/m during baseline. The 
conductivity drops rapidly to 0.4 S/m during the first minute of occlusion and then 
reduces further to 0.3 S/m over the next 10 minutes. Following this, the conductivity drop 
is more gradual and falls to 0.23 S/m over the next 40 minutes and then slowly increases 
to 0.29 S/m during the remainder of the occlusion period. This trend along with the 
standard deviations is illustrated in Figure 4-11. 
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Figure 4-11: Electrical conductivity of myocardium during baseline and 90 min of 
occlusion 
 
The reduction in myocardial conductivity during occlusion is due to the absence 
of the high conductivity perfusate in the myocardium. On reperfusion, the conductivity 
increases almost instantaneously to 0.7 S/m and remains elevated during the entire 20 
min reperfusion period. This elevated conductivity value was seen in the three control 
hearts as well and was shown in Figure 4-7. The conductivity of the perfusate was 
measured to be 1.2 S/m. 
 59 
4.5.2 LDH Analysis of Coronary Effluent 
Samples of the coronary effluent were collected during baseline and reperfusion 
to determine the amount of LDH release. The samples were analyzed as described in 
section 4.4.2. The results show that the highest concentration of LDH is present in the 
sample collected immediately after reperfusion. This is to be expected, since almost all 
the LDH released during the 90 min occlusion period remains in the extracellular space 
and will be washed out all at once when reperfusion begins. The subsequent samples 
contain decreasing amounts of this intracellular protein, as is evident from Table 4-5. The 
concentration of LDH in the sample is expressed in terms of µU/ml. One unit (U) is the 




1 2 3 4 5 
1 4300 1633 21600 6033 4983 
2 550 23733 12417 8767 5367 
3 2483 22967 5167 2400 1250 
4 2017 26017 10767 7017 5983 
5 2500 28950 10150 6717 6233 
6 6783 39317 16300 12167 10250 
7 12717 50800 17733 16100 14483 
Table 4-5: LDH concentration in hearts subject to 90 min of ischemia 
Sample 1 is taken at baseline and sample 2 is taken immediately upon reperfusion. 
Samples 3, 4 and 5 are taken after subsequent 5 min intervals. The average increase in 
LDH release from baseline for all seven hearts is plotted in Figure 4-12. The error bars 
represent the standard deviation of the measurements. 
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Figure 4-12: Average increase in LDH release from baseline after 90 min occlusion 
 
4.6 MYOCARDIAL STUNNING RESULTS 
Eight adult male WKY rat hearts were subject to 15 min of global no-flow 
ischemia followed by 95 min of reperfusion according to the protocol described in the 
earlier section. The measured admittance magnitude and phase angle were used to 
determine the relative permittivity and conductivity of the myocardial tissue during 
baseline, ischemia and reperfusion. LDH samples were collected during baseline and 
reperfusion to investigate the incidence of the cell plasma membrane damage due to 
ischemia. Out of the eight rat hearts subject to this protocol, two hearts did not recover 
from the occlusion and did not develop measurable ventricular pressures over the entire 
reperfusion period. Data from these two hearts were excluded from the data analysis. 
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The LV pressure was monitored in the same manner as in the control hearts 
protocol, by inserting a balloon into the LV. The LVEDP dropped rapidly within the first 
minute of occlusion and remained at -10 mmHg over the entire 15 min occlusion period. 
On reperfusion, the LVEDP increased to 35 mmHg within a minute and then gradually 
dropped to 16 mmHg over the entire 95 min reperfusion period. This is illustrated in 
Figure 4-13. The error bars represent the standard deviation of the measurements over six 
different hearts. 
 

































Figure 4-13: Measured LVEDP during 15 min of occlusion and 95 min of reperfusion 
On reperfusion, six of the eight hearts recovered and were able to achieve 
developed pressures of 45 mmHg after 20 minutes of reperfusion. Thereafter, the 
developed pressures started to drop gradually indicating that the hearts were slowly 
dying. At the end of the 95 min reperfusion period, the developed pressure had dropped 
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to 31 mmHg. This is illustrated in Figure 4-14. The error bars represent the standard 
deviation of the measurements over six different hearts. 
 




































Figure 4-14: Developed pressure during 15 min of occlusion and 95 min of reperfusion 
The heart rate was calculated from the LV pressure measurements to further 
ensure that the hearts had recovered from ischemia during the reperfusion period. It is 
seen that the heart stops beating completely during occlusion. Although there is a large 
standard deviation in the measured heart rate within the first 10 minutes of reperfusion, 
the rate stabilizes to about 275 beats per minute after 35 minutes of reperfusion. This is 
shown in Figure 4-15. 
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Figure 4-15: Heart rate during 15 min of occlusion and 95 min of reperfusion 
 
4.6.1 Confirmation of Stunning 
As previously described, stunning is the mechanical dysfunction that persists after 
reperfusion despite the absence of irreversible damage and despite restoration of normal 
coronary flow. The developed ventricular pressures in these six hearts were compared 
with the pressures developed in the controls to verify that true stunning had occurred. The 
left ventricular end diastolic pressures (LVEDP) of the stunned hearts were also 
compared with the controls. These are shown in Figures 4-16 and 4-17, which confirm 
that the hearts subject to 15 minutes of occlusion eventually recover and attain diastolic 
and developed pressures identical to the controls. It is also evident from these Figures 
that the stunned hearts recover within 35 min of reperfusion. 
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Figure 4-16: Developed LV pressure in stunned vs. control hearts 
 





























Figure 4-17: LVEDP in stunned vs. control hearts 
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4.6.2 Relative Permittivity and Conductivity of Myocardium 
As in the ischemia protocol, the admittance magnitude, phase angle and left 
ventricular developed pressure were monitored in real time during baseline, occlusion 
and reperfusion and used to calculate the relative permittivity (εr) and conductivity (σ) of 
the myocardium. These results are shown in Figures 4-18, 4-19 and 4-20 for baseline and 
at specific times during occlusion and reperfusion. The occlusion was performed at time 
= 0 min and all other times on the graph are relative to the occlusion time. 
 








































Figure 4-18: Relative permittivity of myocardium during baseline, 15 min of occlusion 
and 95 min of reperfusion 
The error bars represent the standard deviation of the measurements over six 
different hearts. The permittivity data do not show any statistically significant changes 
during baseline, occlusion and subsequent reperfusion. The normalized permittivity 
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values do not show any statistically significant trends either (Figure 4-19). This indicates 
that the relative permittivity of the myocardium may not be a good indicator of 
myocardial stunning, and is more useful as an indicator of ischemia and diastolic 
dysfunction. 
 






























Figure 4-19: Normalized permittivity of myocardium during baseline, 15 min of 
occlusion and 95 min of reperfusion 
The average value of myocardial conductivity is 0.67 S/m during baseline. The 
conductivity drops rapidly to 0.54 S/m during the first minute of occlusion and then 
reduces further to 0.33 S/m over the next 14 minutes. On reperfusion, the conductivity 
increases almost instantaneously to 0.84 S/m and remains elevated during the entire 95 






































Figure 4-20: Electrical conductivity of myocardium during baseline, 15 min of occlusion 
and 95 min of reperfusion 
The reduction in myocardial conductivity during occlusion is due to the absence 
of the high conductivity perfusate in the myocardium. This trend is similar to that 
observed in hearts subject to the 90 min ischemia protocol. On reperfusion, the 
conductivity increases almost instantaneously and reaches a maximum value of 0.96 S/m 
during the reperfusion period. This elevated conductivity value was seen in the three 




4.6.3 LDH analysis of Coronary Effluent 
Samples of the coronary effluent were collected during baseline and reperfusion 
to determine the amount of LDH release. Two samples were collected at baseline; one 
immediately after the heart was hung on the system and instrumented and the second one 
after ten minutes of stabilization. The heart was then subjected to 15 min of global no-
flow ischemia, followed by 95 min of reperfusion. The third sample was collected 
immediately upon reperfusion and three more samples were collected at 3 min intervals. 
Seven subsequent samples were collected at 5 min intervals and the last five samples 
were collected at 10 min intervals. The samples were analyzed using the Cayman LDH 
cytotoxicity kit. The results indicate the highest concentration of LDH in the sample 
collected immediately after reperfusion, since almost all the LDH released during the 15 
min occlusion period remains in the extracellular space and will be washed out all at once 
when reperfusion begins. This LDH concentration is lower than that obtained after 90 
min of occlusion, which implies that there is substantially less changes in cell membrane 
permeability for shorter occlusion periods. The subsequent samples contain reducing 




-10 -1 15 18 21 24 29 34 39 
1 533 770 12870 2708 2333 1183 795 395 270 
2 1445 908 26565 2745 1083 933 1008 445 345 
3 1118 883 15675 1703 893 403 538 363 63 
4 558 783 10895 1508 1320 1045 1126 1208 908 
5 420 445 7070 695 658 2045 1501 958 801 
6 1070 1008 4420 3083 5108 5520 4453 3387 2320 
7 1683 1758 9820 3858 2533 1458 1224 991 758 
8 942 525 4550 2450 2142 1683 1125 567 500 






44 49 54 59 69 79 89 99 109 
1 201 133 66 0 0 0 0 0 0 
2 133 183 20 8 45 0 0 0 0 
3 113 0 13 53 3 0 0 0 0 
4 608 641 674 708 683 658 633 608 583 
5 645 595 545 495 445 391 337 283 229 
6 2337 2353 2370 2245 2120 1995 1799 1603 1408 
7 658 558 458 424 391 358 374 391 408 
8 433 358 283 208 133 100 67 33 0 
Table 4-7: LDH concentration in hearts subject to 15 min of ischemia (remainder of 
reperfusion) 
 
The concentration of LDH in the sample is expressed in terms of µU/ml. One unit 
(U) is the amount of enzyme that catalyzes the reaction of 1 µmol of substrate per minute. 
The times represented in Tables 4-6 and 4-7 correspond to the time following the start of 
occlusion. Thus, the occlusion is started at time = 0 min and reperfusion begins at time = 
15 min. The two baseline values are represented by time = -10 min and -1 min. 
Rat #4 and #5 did not recover from the 15 min occlusion and were excluded from 
the analysis. An abnormally high level of LDH release was observed in rat 2 immediately 
upon reperfusion, indicating a high degree of cell necrosis. The average increase in LDH 
release from baseline for the remaining five hearts is plotted in Figure 4-21. The error 
bars represent the standard deviation of the measurements over five different hearts. 
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Figure 4-21: Average change in LDH release from baseline after 15 min occlusion 
All the LDH release occurred within 20 minutes reperfusion, indicating that cell 
necrosis only occurred during the occlusion period and no further cell necrosis occurs 




4.7.1 Myocardial Ischemia 
The myocardial ischemia studies confirm the occurrence of diastolic dysfunction 
during a prolonged period of no-flow ischemia. This is characterized by a rapid increase 
in diastolic pressure within the left ventricle and occurs about 30 minutes after the onset 
of ischemia. An interesting observation here is the behavior of the myocardial 
permittivity during this period. The permittivity reduces during the first 20 min following 
occlusion and then starts to increase. This inflection point is observed prior to the onset of 
diastolic dysfunction and precedes it by 15 minutes. This is illustrated in Figure 4-22. 
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Figure 4-22: Comparison between myocardial permittivity and diastolic pressure during 
baseline and 90 min of occlusion 
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Intracellular calcium levels have been reported to be elevated during ischemia 
[32, 36, 53] and remain elevated until reperfusion. The elevated calcium levels are due to 
the reduced rate of calcium uptake by the sarcoplasmic reticulum. This excess calcium 
binds Troponin I to actin in thin myofilaments to hold the troponin-tropomyosin complex 
in place. This prevents ventricular relaxation and results in stiffening of the ventricular 
muscle. As a result, diastolic pressure increases leading to diastolic dysfunction. Diastolic 
dysfunction is hence caused by calcium overload in the cytoplasm due to a breakdown of 
the functioning of the sarcoplasmic reticulum. This alteration of the intracellular 
electrolyte composition increases the trans-membrane charge distribution across the cell 
membrane and causes a sudden increase in permittivity. The myocardial conductivity, 
however, exhibits no such trends and exhibits no correlation with diastolic dysfunction. 
 
























































Figure 4-23: Comparison between myocardial conductivity and diastolic pressure during 
baseline and 90 min of occlusion 
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4.7.2 Myocardial Stunning 
Eight rats were subject to the myocardial stunning protocol. Only six of the eight 
hearts recovered on reperfusion and these hearts were analyzed for trends in permittivity 
and conductivity during occlusion and reperfusion. The permittivity results did not show 
any statistically significant trends during baseline, occlusion and subsequent reperfusion. 
Out of these six hearts, one of the hearts exhibited abnormally high LDH levels and 
another heart had permittivity values gradually reduce to zero on reperfusion. These two 
hearts were also excluded from the analysis and the average relative permittivity of the   
four remaining hearts is plotted in Figure 4-24. 
 































Figure 4-24: Normalized permittivity of myocardium during baseline, 15 min of 
occlusion and 95 min of reperfusion (n = 4) 
 74 
The normalized permittivity results indicate a gradual decrease in permittivity 
from baseline during the 15 min occlusion period. The elevated LDH activity that has 
been observed during this period indicates increasing plasma membrane permeability due 
to necrosis. As a result, the membrane becomes more permeable to Na+, K+, Ca2+ and 
other ion species. This affects the trans-membrane charge distribution that is responsible 
for the physical origin of permittivity. Since the permittivity is seen to gradually 
decrease, it can be concluded that the trans-membrane charge density decreases during 
the initial 15 min of ischemia. The permittivity increases rapidly upon reperfusion and 
remains elevated above baseline values for about 35 min following reperfusion. The 
elevated permittivity could be an indicator of stunned myocardium, since it was shown in 
section 4.6.1 that the stunned hearts recover after 35 min of reperfusion.  
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Figure 4-25: Comparison between normalized mean permittivity and LVEDP during 
baseline, 15 min of occlusion and 95 min of reperfusion (n = 4) 
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Stunning is characterized by an elevation in end diastolic pressure, possibly due to 
an overload of Ca2+ ions in the cytoplasm. The Ca2+ levels remain elevated during the 
early phase of reperfusion. A specific hypothesis regarding this has been suggested by 
Grinwald [21]. There is an accumulation of intracellular sodium during ischemia due to 
the inhibition of Na+/K+ - ATPase. The Na+/Ca2+ exchanger also remains suppressed by 
acidosis. Increased Na+/H+ exchange due to accumulation of H+ during ischemia also 
favors sodium overload. On reperfusion, the rapid reversal of acidosis allows the 
reactivation of the Na+/Ca2+ exchanger when sodium overload has not been resolved. The 
enhanced sodium efflux causes movement of calcium into the cells, causing the Ca2+ 
levels to remain elevated during the early phase of reperfusion. 
This elevation in intracellular Ca2+ along with a gradual restoration of membrane 
permeability to normal levels could cause an increase in myocardial permittivity (similar 
to that observed during the 90 min ischemia protocol). Once the functioning of the 
sarcoplasmic reticulum and other calcium transport pumps is restored, the Ca2+ levels in 
the cells return to normal and the diastolic pressures reduce to normal values. The 
permittivity should hence return to baseline, thereby indicating recovery from stunning. 
This is in contrast with the ischemic hearts where the hearts do not recover once diastolic 
dysfunction has set in. 
The myocardial conductivity in the four selected stunned hearts was compared 
with the controls and is shown in Figure 4-26. The occlusion causes a sudden drop in 
myocardial conductivity due to the absence of the high conductivity perfusion fluid. On 
reperfusion, the conductivity returns to normal value almost instantly and is not affected 
by the stunned state of the myocardium. 
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Figure 4-26: Myocardial conductivity in stunned vs. control hearts (n = 4) 
From the above graph, it is evident that myocardial conductivity cannot be used as 
an indicator of stunning in the myocardium. It may be useful in the detection of no-flow 
ischemia, since the cessation of blood flow will cause a rapid decrease in the conductivity 
of the tissue. 
 
 77 
4.7.3 Comparison between Ischemia and Stunning 
 The measured permittivity and conductivity during ischemia and stunning has 
been described in detail in the previous sections. The permittivity and conductivity values 
were normalized with respect to baseline values to enable comparison their comparison 
between ischemia and stunning. Normalizing with respect to baseline also causes each 
heart to serve as its own control, thereby eliminating differences that arise among 
different hearts as a result of baseline variations. 
 
 












































Figure 4-27: Normalized relative permittivity – ischemia vs. stunning 
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5.1 SUMMARY OF FINDINGS 
A novel instrument (RamsES I) was designed and developed to determine the 
magnitude and phase angle of the electrical admittance of tissue in real time. The system 
was tested on isolated rat heart models of stunning and ischemia. The key findings have 
been listed below and summarized in Table 5-1. 
• Myocardial permittivity decreases during the first 20 min of global no flow ischemia. 
• Prolonged ischemia (30 min in the isolated rat heart) eventually causes diastolic 
dysfunction, verified by an increase in LVEDP. 
• The permittivity increases prior to the onset of diastolic dysfunction in the left 
ventricle. 
• Reperfusion after 15 min of occlusion results in myocardial stunning, with the tissue 
recovering after 35 min of reperfusion. 
• The permittivity is temporarily elevated in the stunned myocardium and returns to 
baseline on recovery from stunning. 
• The myocardial conductivity decreases drastically during occlusion and returns back 
to baseline almost instantaneously upon reperfusion. 
• The conductivity measurements are dominated by the high conductivity perfusate in 
the myocardium and are not affected by the state of the myocardium. 
• Increase in myocardial permittivity is as good an indicator of diastolic dysfunction as 
an increase in diastolic pressure. 
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The effects of myocardial ischemia, stunning and diastolic dysfunction on the 
permittivity, conductivity and LVEDP are summarized in Figures 5-1 and 5-2 as well as 
in Table 5-1. The relative permittivity of the myocardium is seen to decrease by 15% 
from baseline during 20 min of global no flow ischemia until the onset of diastolic 
dysfunction. The conductivity is also decreased due to the absence of the high 
conductivity perfusate (blood) in the myocardium. The onset of diastolic dysfunction is 
seen to increase the permittivity to 18% above the baseline values. Reperfusion before the 
onset of diastolic dysfunction causes the permittivity to rise to 10% above baseline 
(stunned myocardium) and gradually decrease towards baseline as the heart recovers 




Figure 5-1: Trends in myocardial permittivity and conductivity in normal, transient 
ischemic, stunned and recovered myocardium 
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Figure 5-2: Trends in myocardial permittivity and conductivity during baseline, 
transient ischemia and diastolic dysfunction 
 
 Permittivity Conductivity LVEDP 
Ischemia decreases decreases decreases 
Stunning increases unchanged increases 
Diastolic dysfunction increases decreases increases 
Table 5-1: Summary of electrical properties and LV pressure during ischemia and 
stunning 
The trans-membrane charge density is responsible for the physical origin of 
myocardial permittivity. During global no flow ischemia, cell necrosis occurs and is 
accompanied by mitochondrial swelling and increased plasma membrane permeability [6, 
7, 52, 59]. This is manifested by elevated levels of LDH in the extracellular space. As a 
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result, the membrane may become more permeable to several ion species like Na+, K+ 
and Ca2+. This would reduce the trans-membrane charge distribution, thereby lowering 
the measured tissue permittivity. Diastolic dysfunction is characterized by a rapid 
increase in LVEDP due to calcium overload in the cytoplasm (due to breakdown in the 
functioning of the sarcoplasmic reticulum [6, 7, 52]). This alteration of the intracellular 
electrolyte composition increases the trans-membrane charge distribution across the cell 
membrane and would explain the sudden increase in permittivity. Myocardial stunning 
also causes an intracellular calcium overload, primarily due to the reactivation of the 
Na+/Ca2+ exchanger when the intracellular sodium overload has not been resolved. Since 
coronary perfusion has been restored in stunned myocardium, the functioning of voltage 
gated membrane ion channels is restored and membrane permeability gradually returns to 
normal. All these mechanisms cause rapid changes in the intracellular and extracellular 
ion concentrations and affect the charge distribution across the cell membranes. This 
could explain the increased myocardial permittivity during stunning. 
 
5.2 FUTURE WORK 
The effect of diastolic dysfunction on myocardial permittivity has been 
established with a high level of certainty. However, determination of the exact effect of 
myocardial stunning on the permittivity requires extensive further research. The degree of 
stunning and the recovery duration are highly dependent on baseline pressures and heart 
rates, making it necessary to perform the studies on a large number of hearts and divide 
the hearts into various groups depending on baseline parameters. Repeated experiments 
of the stunning protocol on a large number of hearts may also help identify subtle trends 
in the permittivity values during stunning and recovery. 
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The extent of tissue necrosis was verified by measuring the amount of LDH 
release. This is a fairly straightforward process and was accomplished using 
commercially available kits. However, other biomarkers like troponin I are highly 
specific to cardiac tissue and could have been used instead of LDH as a more accurate 
indicator of cardiac cell death. The hearts could also be fixed in neutral buffered formalin 
and examined using various histological techniques (Hematoxylin and Eosin staining for 
necrosis and TUNEL assays for apoptosis) for additional information on the extent of cell 
death. 
The use of the patch clamp technique to study individual ion channels in 
myocardial cells will enable better understanding of the changes in the intracellular ion 
compositions that occur during ischemia, reperfusion and stunning. This would help 
identify intracellular and extracellular mechanisms responsible for the measured changes 
in permittivity and conductivity of the myocardium. 
The RamsES I system can be upgraded to calculate the conductivity and 
permittivity in real time from the admittance magnitude and phase measurements. This 
would enable real time monitoring of hearts for calcium overload or myocardial 
stiffening during vascular surgery or other cardiopulmonary bypass procedures. The 
system can also be used to search for necrotic areas on the heart during cardiac bypass 
surgery. Another application would be to monitor the health of donor hearts during 
transport prior to implantation. The system may also be extended to monitor ischemia in 
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